Displaying 151 - 160 of 293
Vancouver in-person ‘Blood Cancer Connect & Learn’
Updated:
More than 100 people impacted by blood cancer registered for the event in Vancouver on Saturday, September 14th, 2024 at the Jewish Community Centre. Called “Blood Cancer Connect & Learn.” this was the third in-person community education event held by LLSC since the pandemic…
Many cancer survivors and caregivers face mental health challenges post-cancer
Updated:
Mental health challenges such as depression, anxiety and PTSD, can exist in blood cancer survivors and their caregivers even years after treatment is over.
Spotlight on GvHD, a serious side effect of stem cell transplants
Updated:
Graft vs. Host Disease (GvHD) is a serious side effect that commonly affects people who've undergone an allogeneic stem cell transplant (SCT), meaning they've received stem cells to treat their blood cancer. LLSC presented at the International GvHD Symposium in October…
Jay
Updated:
I had a pretty successful career and was thinking about starting a family of my own when I learned I had a blood cancer.
The Collings Stevens Family Foundation partners with LLSC to help Canadians impacted by CML
Updated:
The Leukemia & Lymphoma Society of Canada, with partners like The Collings Stevens Family Foundation, is informing and empowering people impacted by chronic myeloid leukemia (CML), a once-fatal blood cancer now a manageable disease.
Work for LLSC
Updated:
At the Leukemia & Lymphoma Society of Canada, we are driven by our ambition to change the course of the blood cancer experience for every person in Canada. This vision is a huge undertaking requiring a culture that fosters big ideas, bold actions, and a great amount of heart.
New AI research award recipient supported by UFCW
Updated:
One of the exciting, novel aspects of LLSC’s latest blood cancer research awards is the introduction of the Artificial Intelligence (AI) Catalyst Grant, for the application of AI to blood cancer research.
Kent
Updated:
After getting a stem cell transplant, and another week of chemo for CLL that Kent was diagnosed with at age 42 in 2006, one of the lingering effects was chemo induced cognitive impairment, sometimes referred to as “brain fog.” It caused his short-term memory issues and he began…
Accelerating and expanding blood cancer research
Updated:
The Leukemia and Lymphoma Society of Canada (LLSC) has committed nearly $5 million to blood cancer research in Canada in 2024 - with another $1.25 million from our partners!